RHÖN-KLINIKUM AG 

20.06.2012 11:15

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

On 19 June 2012, SEB AG, Frankfurt, Germany, and Skandinaviska Enskilda
Banken AB (publ), Stockholm, Sweden, notified us pursuant to section 25
WpHG of the following:

1) SEB AG, Frankfurt, Germany, notified us pursuant to section 25 para. 1
WpHG of the following:

On 18 June 2012, SEB AG fell below the threshold of 10% of the voting
rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, SEB AG held 9.99% of the voting rights in
RHÖN-KLINIKUM AG (equals 13,803,628 voting rights). From these voting
rights a proportion of 9.63% (equals 13,318,128 voting rights) is based on
voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.35%
(equals 485,500 voting rights) is based on (financial/other) instruments
pursuant to section 25 WpHG. From the voting rights based on instruments
pursuant to section 25 WpHG a proportion of 0.00% (equals 0 voting rights)
is held indirectly. Exercise period of the instruments pursuant to section
25 WpHG is any time until cancellation/claim for the return of shares,
maturity upon cancellation/claim for the return of shares.

2) Skandinaviska Enskilda Banken AB (publ), Stockholm, Sweden, notified us
pursuant to section 25 WpHG of the following:

On 18 June 2012, Skandinaviska Enskilda Banken AB (publ) fell below the
threshold of 15% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, Skandinaviska
Enskilda Banken AB (publ) held 14.74% of the voting rights in RHÖN-KLINIKUM
AG (equals 20,371,827 voting rights). From these voting rights a proportion
of 9.63% (equals 13,318,128 voting rights) is based on voting rights
pursuant to sections 21, 22 WpHG and a proportion of 5.10% (equals
7,053,699 voting rights) is based on (financial/other) instruments pursuant
to section 25 WpHG. From the voting rights based on instruments pursuant to
section 25 WpHG a proportion of 0.35% (equals 485,500 voting rights) is
held indirectly (chain of controlled undertakings: SEB AG, Ulmenstraße 30,
60325 Frankfurt, Germany).  Exercise period of the instruments pursuant to
section 25 WpHG is any time until cancellation/claim for the return of
shares, maturity upon cancellation/claim for the return of shares.

Bad Neustadt a.d. Saale, 20 June 2012

The Board of Management

___________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



20.06.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service